In particular, no statistical prognostic value of CDKN2A in breast cancer was observed (Fig. 2A), while patients with higher expression of SLC31A1 displayed a poor prognosis (Fig. 2B). The gene discussed is SLC31A1; the disease is breast carcinoma.